Veracyte
VCYT
25.13
+0.09
+0.36%
Veracyte
US · VCYT
#2330 by market cap
Listed 1970
25.13
+0.09
+0.36%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
About Veracyte
Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.
- Founded
- 2006
- CEO
- Mr. Marc A. Stapley
- Employees
- 755
- Headquarters
- South San Francisco, California, United States of America
- Fiscal year end
- 12-31
- Website
- veracyte.com
Company profile
- Exchange
- US
- Symbol
- VCYT
- Market-cap rank
- #2330
- Listing date
- 1970-01-01
- Market cap
- 2.03B
- Float cap
- 2.02B
- Shares out
- 80.70M
- Float shares
- 80.19M
Sectors & themes
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Veracyte discussion 0 comments